Merus_October_2022_210_88210
Loading viewer...
investor_presentation
Format: PDF investor_presentation
This investor presentation provides an update on Merus's MCLA-129, highlighting its potential impact on cancer treatment and clinical trial progress.
Related tags
More from Merus
View all →
Similar investor_presentations from other companies
Browse all →Rocket Pharmaceuticals Investor Presentation — May 2022
investor_presentationinvestor_presentation
50 Pages
Rocket Pharmaceuticals
investor_presentation
Auric Mining
